Monday, September 27, 2021 (9:30 am - 1:00 pm)

LIFE SCIENCES TECHNOLOGY FORUM 2021 - Phygital meeting
Life Sciences in the post-Covid era

HUMAN TECHNOPOLE V.le Rita Levi-Montalcini, 1 - 20157 MILANO

The European House - Ambrosetti launched in 2015 the Technology Forum Life Sciences, the event of maximum visibility of the Community Life Sciences, the multistakeholder platform for discussion and comparison on life sciences that has the mission to "contribute to the enhancement of the ecosystem of research and innovation in the Life Sciences sector in Italy, promoting centers of excellence and networking national stakeholders to promote the transfer of knowledge, the development of new projects and improve the positioning and competitiveness of the system-Country at the international level".
Starting in 2020, the Technolgy Forum Life Sciences has been transformed into a Week, with a main event and a series of thematic meetings during the last week of September.
The seventh edition of the #TFLSW, organized in collaboration with Alexion, Area Science Park, ATOS, BiovelocITA, Fondazione Telethon, Human Technopole, Insilicotrials, Istituto Italiano di Tecnologia, Sofinnova Partners and Hub Innovazione Trentino, will deepen during the first day central aspects of the sector, such as the lessons learned during the Covid-19 emergency fight, future trends and the role played by funding in the sector; while in the following days space will be given to debate and deepen the verticals covered by the 2021 path of the Community: Big Data & AI in Life Sciences, Technolgy Transfer, Genomics Observatory and Road to Bio€quity Europe 2022.

Speakers

Lorenzo Angeloni

Director General for the Promotion of the Country System at Farnesina

Alessandra Biffi

Professor of Pediatrics, UNIVERSITY OF PADUA; Director of the Pediatric Oncohaematology and Haematopoietic Stem Cell Transplantation Clinic at the University Hospital of Padua.

Tonia Cartolano

Sky Tg24, Deputy Editor, Anchor and Reporter

Ewan Birney

European Molecular Biology Laboratory, Deputy Director

Giusi Condorelli

Medical staff, Italian Embassy in Beijing

Valerio De Molli

Managing Partner & CEO, The European House - Ambrosetti; Director of London’s Ambrosetti Group Limited

Sergio Dompé

President e CEO, Dompé Farmaceutici

Alessandra Fanciulli

Clinical Research Fellow at the Department of Neurology, Medical University of Innsbruck

Paolo Fundarò

Chief Executive Officer, GENEXTRA

Giuseppe Novelli

Advisor Community Life Sciences; Member and Coordinator of the Genetics Subgroup of the National Committee for Biosafety, Biotechnology and Life Sciences - CNBBSV

Fabrizio Sala

Councillor for Education, University, Research, Innovation and Simplification, LOMBARDY REGION

Graziano Seghezzi

Managing Partner, SOFINNOVA PARTNERS

Marco Simoni

President, HUMAN TECHNOPOLE

Alessandro Tappi

Chief Investment Officer, European Investment Fund

Antonella Viola

Immunologist

Programme

September 27, 2021
9:30 am - 12:30 pm Life sciences in the post-covid era
12:30 pm - 1:00 pm Debate

Video of the meeting

Le Scienze della Vita nell’era post-Covid
Lorenzo Angeloni
Farnesina, Direttore Generale per la Promozione del Sistema Paese
Alessandra Biffi
UNIVERSITA' DEGLI STUDI DI PADOVA; , Professore ordinario di Pediatria, dirige la clinica di oncoematologia pediatrica
Tonia Cartolano
Sky Tg24, Vice Caporedattore, Anchor e Reporter
Giusi Condorelli
Ambasciata d’Italia a Pechino, Addetto Sanitario
Valerio De Molli
The European House - Ambrosetti, Managing Partner e Amministratore Delegato
Sergio Dompé
Dompé Farmaceutici, Presidente e CEO
Alessandra Fanciulli
Medical University of Innsbruck, Clinical Research Fellow at the Department of Neurology
Giuseppe Novelli
Advisor Community Life Sciences, Membro e Coordinatore del Sottogruppo di Genetica del CNBBSV
Fabrizio Sala
REGIONE LOMBARDIA, Assessore per l'Istruzione, Università, Ricerca, Innovazione e Semplificazione
Simone Seghezzi
SOFINNOVA PARTNERS, Managing Partner
Marco Simoni
HUMAN TECHNOPOLE, Presidente
Alessandro Tappi
European Investment Fund, Chief Investment Officer
Antonella Viola
Immunologa